Newly Formed Council Issues Statement On Healthcare Provider Gaps Related To Education And Management Of Fibromyalgia Syndrome
Main Category: FibromyalgiaAlso Included In: Headache / Migraine
Article Date: 31 Dec 2007 - 0:00 PDT
| Patient / Public: | ![]() |
3.38 (13 votes) |
| Healthcare Prof: | ![]() |
3.75 (4 votes) |
| Article Opinions: | 1 posts |
The newly formed Advisory Council on Fibromyalgia Education (ACFE) comprised of internationally recognized clinicians and researchers and developed to identify and provide solutions to educational gaps and barriers in the area of fibromyalgia syndrome issued a statement stating that several significant gaps exist in the identification, diagnosis and management of fibromyalgia patients.
"The gaps and barriers identified among healthcare providers include a substantial lack of awareness about the disorder and a lack of confidence in the ability of the physicians to diagnosis it. As a result, misdiagnosis, fragmentation of patient care, and an increased cost of care are plaguing the management of fibromyalgia syndrome," said I. Jon Russell, MD, PhD, Associate Professor of Medicine at The University of Texas Health Science Center at San Antonio and Director of the University Clinical Research Center. "Each of these barriers contributes to poor patient care and outcomes. Ideally, the management of patients with fibromyalgia syndrome should be individualized, multimodal, multidisciplinary, and should be expected to extend over weeks to months with a continuum of care during that time," added Dr. Russell.
The goal of the ACFE is to bring together a multidisciplinary group of national thought leaders in the area of fibromyalgia syndrome to provide insight into the core issues that cause physicians' barriers to patient care, and together deliver strategic direction in addressing those barriers. Current members include Misha-Miroslav Backonja, MD, Robert Bennett, MD, Michael Clark, MD, MPH, Daniel Clauw, MD, Don Goldenberg, MD, Rakesh Jain, MD, MPH, Kim Dupree Jones RN, PhD, FNP, Lynne Matallana, President of NFA, Bill McCarberg, MD, FABPM, Philip J. Mease, MD, Harvey Moldofsky, MD, FRCPC, I. Jon Russell, MD, PhD, Dennis Turk, PhD, David A. Williams, PhD and Patrick Wood, MD.
The council represents the areas of rheumatology, psychiatry, primary care, neurology and nursing as well as other healthcare groups and thus presents a platform offering insight from multiple perspectives. The council will also address needs in other disease areas that have similar clinical features, for example chronic fatigue syndrome, chronic headache, and temporomandibular joint syndrome,
"Having a group of such pre-eminent thought leaders provide such input and direction will allow the development of much needed evidence-based education in the area of fibromyalgia syndrome," states Seanne Murray, CEO of MJ Consulting Group, who jointly developed the ACFE with the National Fibromyalgia Association (NFA), and Gullapalli and Associates (G&A).
About the National Fibromyalgia Association
The NFA, founded in 1997 by Lynne Matallana, is the largest nonprofit organization dedicated to decreasing the burden of fibromyalgia through education, research and patient advocacy. The NFA leads a national and international effort to create a voice for providers, researchers and patients who deal with fibromyalgia by leading the development and support of educational activities, awareness events, fibromyalgia research, media coverage, and facilitation of increased collaboration between patients and providers. The NFA's philosophy is to help empower all stakeholders in fibromyalgia and to provide them with a new level of hope for the future.
National Fibromyalgia Association
About MJ Consulting Group
MJ Consulting Group ("MJ") collaborates with academic centers of excellence, non-profit associations, and medical education companies dedicated to advancing medical education. While reinforcing a collaborative approach, MJ's goal is to raise awareness of and foster dialogue about solutions to address educational gaps and needs among healthcare providers. MJ identifies, develops and manages collaborative relationships with established organizations, educational partners and channels to develop communication strategies designed to address key educational gaps and needs among healthcare providers. As a facilitator in the medical education industry, its mission is to deliver clearly defined communications strategies aimed to improve the knowledge, skills and clinical behavior of healthcare providers through proven health education models thus impacting patient care and outcomes.
MJ Consulting Group
About G&A
Gullapalli & Associates (G&A) is a consulting firm specializing in facilitating strategic collaboration between key stakeholders in the medical education community. G&A facilitates the development of integrated educational initiatives through evidence based health education models, ensuring consistent educational strategy, goals, and objectives across multiple channels. G&A also identifies and manages a range of educational collaborative partners, channels, and resources to enhance the educational impact of the services provided.
Gullapalli & Associates
Visit our fibromyalgia section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/92178.php>
APA
http://www.medicalnewstoday.com/releases/92178.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Study For Gaps In Diagnosis & Treatment Of Fibromyalgia
posted by Maggie Rae on 4 Jan 2008 at 3:29 pmWell, this has been long overdue, but I am happy to see that there is finally some attention being paid to this very painful illness and how to serve the patients better. I live in Canada, and even with the diagnosis, I have still been struggling to find an answer to pain relief, as dr's here will only prescribe anti-inflammatories and I can't take them due to stomach problems when I do take them. If this whole study can get us closer to a form of pain relief that actually works, I , and many others, will be very relieved. This article is encouraging that Fibromyalgia is finally getting some of the real attention it needs.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




